WDATA...THREE YEARS LATER.     THE 3 YEARS WHICH HAVE ELAPSED SINCE THE FIRST UK TEST TRIAL OF PRESTEL HAVENOT SEEN AS FAST A GROWTH IN USAGE AS WAS ESTIMATED. UK EXPERIENCE WITHPRESTEL IS REVIEWED IN LIGHT OF THE DEVELOPMENT OF COMPETING SYSTEMS BYCANADA, FRANCE AND JAPAN. THE IMPLICATIONS FOR VIEWDATA SYSTEMS FOR AUSTRALIAARE STUDIED